THE LIMITATIONS OF HEPARIN THERAPY AFTER ARTERIAL RECONSTRUCTION.
D000227:Adenine Nucleotides; D000925:Anticoagulants; D001779:Blood Coagulation Factors; D001792:Blood Platelets; D001808:Blood Vessels / Q000637:transplantation*; D002951:Citrates; D005337:Fibrin; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D010600:Pharmacology; D013927:Thrombosis; D014116:Toxicology
D000227:Adenine Nucleotides; D000925:Anticoagulants; D001779:Blood Coagulation Factors; D002951:Citrates; D005337:Fibrin; D006493:Heparin
ADENINE NUCLEOTIDES; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; BLOOD VESSEL TRANSPLANTATION; CITRATES; FIBRIN; HEPARIN, THERAPEUTIC; PHARMACOLOGY; THROMBOSIS; TOXICOLOGIC REPORT